Delhi HC Quashes Centre's Notification to Ban FDC Drugs
The Delhi High Court on Thursday quashed the Centre's notification to ban 344 fixed dose combination (FDC) medicines.
New Delhi: The Delhi High Court on Thursday quashed the Centre's notification to ban 344 fixed dose combination (FDC) medicines.
The brands included D'Cold Total, Corex cough syrup, and Vicks Action 500, among others.
Justice R.S. Endlaw, allowing the 454 pleas filed by the pharma companies, quashed the Centre's notification issued on March 10.
Companies like Pfizer, Glenmark, Procter and Gamble, Reckitt Benckiser, Cipla and others had moved the court against the government decision. The court had granted stay on the notification.
The government had told the court that FDC medicines sold by pharma majors "endanger patient safety".
It had banned the drugs on the ground that they involve risk to humans and hence needed to be withdrawn immediately and contended that safer alternatives were available.
The pharma companies had argued that the ban order was passed without considering clinical data and had termed the government's claim as absurd.
Get the best of News18 delivered to your inbox - subscribe to News18 Daybreak. Follow News18.com on Twitter, Instagram, Facebook, Telegram, TikTok and on YouTube, and stay in the know with what's happening in the world around you – in real time.
Recommended For You
- It's 3 Idiots Reunion as Mona Singh Joins Aamir Khan-Kareena Kapoor Starrer Laal Singh Chaddha
- Maneka Gandhi Sends Help Within an Hour After Journalist Tweets Image of Injured Monkey
- Kerala MLA Asked Locals to Gift Him Books, Now He's Donating Them to School Libraries
- Internet's Favourite Singer to Trolls' Easiest Target: Can We Leave Ranu Mondal Alone?
- Xiaomi Redmi Note 8 Pro Review: A Lot of Style And Even More Substance